ÂÜÀòÂÒÂ×

Dr. Rohit Loomba is a Professor of Medicine, Director of Hepatology, and Vice Chief of the Division of Gastroenterology at the University of California at San Diego. He is an internationally recognized thought leader in the management of nonalcoholic fatty liver disease and has established a thriving and vibrant center for clinical care and research in NAFLD at UCSD.

Dr. Loomba is the founding director of the UCSD NAFLD Research Center. Along with his collaborators, he has led several innovative applications such as the establishment of MRI-PDFF as a non-invasive biomarker of treatment response in early phase trials in NASH, which has now been adopted in more than 50 clinical trials conducted worldwide. In addition, Dr. Loomba served as the Chair of the NAFLD, Special Interest Group of the American Association for the Study of Liver Diseases, and is currently an elected member of the National Board of Directors of the American Liver Foundation and the American Society of Clinical Investigation.

Dr. Loomba has published more than 300 manuscripts and has an H-index of 94. He is among the top 1% of the globally highly cited scientists across all fields in 2019 and 2020 by Web of Science. He served as the Deputy Editor of HEPATOLOGY, the official journal of the AASLD, from 2017-2021, and continues to serve on the Editorial Board of Gastroenterology, Journal of Hepatology, GUT, and Nature Reviews in Gastroenterology and Hepatology. UCSD Gastroenterology and Hepatology was listed as the number 1 research and education program in the World by the US World News ranking in 2021.